FTCM
RVPH

First Trust Capital Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

First Trust Capital Management’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-9
Closed -$2K – 109
2020
Q2 		$2K Buy
+9
New +$1.92K ﹤0.01% 68

Other funds holding RVPH

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $469M AUM 32.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

First Trust Capital Management's RVPH Position: Q3 2020 in Review

First Trust Capital Management sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q3 2020, closing a stake of 9 shares — an estimated $2K sold.

First Trust Capital Management first reported a position in RVPH in Q2 2020 and held it in 1 quarter. The position peaked at $2K in Q2 2020. 13 funds tracked by Wall St. Rank hold RVPH as of Q3 2020.

  • First Trust Capital Management reported no remaining REVIVA PHARMA HLDGS INC position as of Q3 2020 after selling out during the quarter.
  • First Trust Capital Management sold 9 REVIVA PHARMA HLDGS INC shares in Q3 2020, an estimated $2K.
  • First Trust Capital Management first reported a position in REVIVA PHARMA HLDGS INC in Q2 2020 and held it in 1 quarter.
  • First Trust Capital Management's REVIVA PHARMA HLDGS INC position peaked at $2K in Q2 2020.
  • 13 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q3 2020.

Based on First Trust Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.